Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred R Hirsch

Showing results (21-30 of 405) with videos related to

Pageof 41
Sort By:
Seminars in Oncology|February 26, 2004
The role of HER2/neu expression and trastuzumab in non-small cell lung cancerFred R Hirsch, Corey J Langer
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Chemoprevention of lung cancer: current status and future prospectsNico van Zandwijk, Fred R Hirsch
Nature Reviews. Clinical Oncology|November 11, 2015
Adjuvant TKIs in NSCLC: what can we learn from RADIANT?Fred R Hirsch, Paul A Bunn
The Lancet. Respiratory Medicine|January 28, 2014
Progress in research on screening and genetics in lung cancerFred R Hirsch, Paul A Bunn
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Lung cancer chemoprevention: moving from concept to a realityJames L Mulshine, Fred R Hirsch
Lancet (London, England)|May 5, 2009
Patient selection criteria and the FLEX StudyRoy S Herbst, Fred R Hirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?Fred R Hirsch, Paul A Bunn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Advances in the biology of lung cancer chemopreventionFred R Hirsch, Scott M Lippman
The Lancet. Oncology|June 21, 2013
FASTACT-2: but don't act too fastFred R Hirsch, David R Gandara
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Using molecular markers in sputum for the early detection of lung cancer: a reviewTimothy C Kennedy, Fred R Hirsch
Pageof 41

Showing results (21-30 of 405) with videos related to

Sort By:
Pageof 41
Seminars in Oncology|February 26, 2004
The role of HER2/neu expression and trastuzumab in non-small cell lung cancerFred R Hirsch, Corey J Langer
Lung Cancer (Amsterdam, Netherlands)|November 13, 2003
Chemoprevention of lung cancer: current status and future prospectsNico van Zandwijk, Fred R Hirsch
Nature Reviews. Clinical Oncology|November 11, 2015
Adjuvant TKIs in NSCLC: what can we learn from RADIANT?Fred R Hirsch, Paul A Bunn
The Lancet. Respiratory Medicine|January 28, 2014
Progress in research on screening and genetics in lung cancerFred R Hirsch, Paul A Bunn
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Lung cancer chemoprevention: moving from concept to a realityJames L Mulshine, Fred R Hirsch
Lancet (London, England)|May 5, 2009
Patient selection criteria and the FLEX StudyRoy S Herbst, Fred R Hirsch
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2005
Epidermal growth factor receptor inhibitors in lung cancer: smaller or larger molecules, selected or unselected populations?Fred R Hirsch, Paul A Bunn
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Advances in the biology of lung cancer chemopreventionFred R Hirsch, Scott M Lippman
The Lancet. Oncology|June 21, 2013
FASTACT-2: but don't act too fastFred R Hirsch, David R Gandara
Lung Cancer (Amsterdam, Netherlands)|November 24, 2004
Using molecular markers in sputum for the early detection of lung cancer: a reviewTimothy C Kennedy, Fred R Hirsch
Pageof 41